FDA Commissioner Marty Makary said the agency may fast-track new drugs from pharmaceutical companies that “equalize” the cost ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

The selection of a first-line treatment for patients with advanced EGFR -positive non-small cell lung cancer (NSCLC) has become increasingly complex in recent years with available options now ...

Bernstein analyst Justin Smith maintained a Hold rating on Pfizer yesterday and set a price target of $30.00. The company’s shares closed yesterday at $25.62. Don’t Miss TipRa ...

The deal gives AstraZeneca’s rare disease unit Alexion access to specialized capsids developed by the Japanese biotech JCR ...

More than 450,000 extra Queenslanders will be eligible to receive the Pfizer vaccine after a change to the advice around AstraZeneca, with the Health Minister warning of possible delays as the rollout ...

AstraZeneca’s rare disease unit Alexion has penned a $825 million deal for adeno-associated virus (AAV) capsids from existing ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

US President Donald Trump has threatened to impose tariffs at a rate as high as 200pc on imported drugs on Tuesday night in ...

Follow the latest on Trump’s tariffs; Donald Trump has threatened to introduce tariffs of up to 200pc on pharmaceutical ...